Endothelial progenitor cells and spleen: new insights in regeneration medicine.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19878079.
- Also identified by DOI 10.3109/14653240903300674.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As a promising concept for regeneration medicine, endothelial progenitor cell (EPC) therapy represents a novel strategy for a variety of diseases. Increasing evidence suggests that the spleen, a traditionally dispensable organ, acts as a major reservoir during EPC trafficking and plays an important role regarding the modulation of circulating EPC kinetics. Moreover, infusion of splenic EPC can restore endothelial function and promote neovascularization, indicating an available resource for EPC transplantation. Thus a discussion of the role of the spleen with respect to EPC may provide novel information for management of EPC therapy.
Medical subject headings
- Endothelial Cells
- Hematopoietic Stem Cell Transplantation
- Neovascularization, Physiologic
- Regeneration
- Spleen
- Stem Cells